FACTANKER · measured, cited, anchored official records connected
FACTANKERSearch ↗

SEC EDGAR CompanyFacts fact · reporting period

Gene Biotherapeutics, Inc.: cashflow_financing

One fact, its scope and the complete path back to the official record.

Period: 2020-01-01 – 2020-12-31Status: currentProvenance attached

Cite: FACTANKER, https://factanker.com/fact/c920c9f8-b350-427e-806a-e6e65aec3af6

Reported value

$1.522M{"amount": 1522065, "concept": "us-gaap:NetCashProvidedByUsedInFinancingActivities", "currency": "USD"}
Entity
Gene Biotherapeutics, Inc.
Metric
cashflow_financing
Period
2020-01-01 – 2020-12-31
Status
current
Source
SEC EDGAR CompanyFacts

Provenance

Official reference0001493152-22-008205 · Open the official SEC filing →
Source licenseUS-PD-17USC105
Retrieved2026-08-19T07:56:01.183017+02:00
Raw response SHA-256f7bde1a401b286c74a2fd824ee1df541…
Official-identifier pathhttps://factanker.com/fact/sec/cik-0000772320/cashflow-financing/2020-12-31 (CIK, metric, reporting date)
History
  • no predecessors — first report

Why this page exists

The UUID above is the stable citation anchor: it never changes, and corrections supersede rather than overwrite. Cite the URL and any reader — human or machine — can verify the value against the official filing.

All facts for this organization →Query facts through API / MCP →Versioning policy →
From the Record
18% of job ads mention AI. Only 2% are AI jobs — and two thirds of the mentions come from 22 companies that say it in every ad.
Read the findingSearch 53 million companies